Immunodeficiency and cancer: prospects for correction
- 1 August 2003
- journal article
- review article
- Published by Elsevier in International Immunopharmacology
- Vol. 3 (8) , 1061-1071
- https://doi.org/10.1016/s1567-5769(03)00060-2
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Immunotherapy with natural interleukins and/or thymosin α1 potently augments T-lymphocyte responses of hydrocortisone-treated aged miceInternational Journal of Immunopharmacology, 1995
- The Immunology of Breast CancerClinical Immunotherapeutics, 1995
- The treatment of zinc deficiency is an immunotherapyInternational Journal of Immunopharmacology, 1995
- Zinc induces thymulin secretion from human thymic epithelial cells In vitro and augments splenocyte and thymocyte responses In vivoInternational Journal of Immunopharmacology, 1995
- Malignancy After Immunosuppressive TherapyClinical Immunotherapeutics, 1995
- Immunology of Head and Neck CancerClinical Immunotherapeutics, 1995
- Biological Implications of HLA‐DR Expression in TumoursScandinavian Journal of Immunology, 1995
- T-cell adjuvantsInternational Journal of Immunopharmacology, 1994
- Suppressor mechanisms in tumor immunityCellular and Molecular Life Sciences, 1983
- Inhibitory factors derived from human tumors: Isolation of factors which suppress macrophage mediated cytotoxicityInternational Journal of Immunopharmacology, 1983